Anesthetic induction with ketamine inhibits platelet activation before, during, and after cardiopulmonary bypass in baboons

Artificial Organs

Volumn 28, Issue 10, 2004, Pages 959-962

  Ündar, Akif ^a,b,e   Eichstaedt, Harald C ^c   Clubb Jr , Fred J ^c   Lu, Mason ^d   Bigley, Joyce E ^c   Deady, Blake A ^c   Porter, Aimee ^c   Vaughn, William K ^c   Fung, Michael ^d  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS HEART INSTITUTE   (United States)

^d Tanox Biosystems Inc   (United States)

^e PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Baboons; Cardiopulmonary bypass; Ketamine; Mab 166 32; Platelet inhibition

Indexed keywords

ANESTHETICS; CHEMICAL ACTIVATION; MONOCLONAL ANTIBODIES; PLATELETS;

BABOON; CARDIOPULMONARY BYPASS; HYPOTHERMIC; INTRAMUSCULAR INJECTIONS; ISOFLURANE; KETAMINE; MEAN WEIGHT; MONOCLONAL ANTIBODY 166-32; PLATELET ACTIVATION; PLATELET INHIBITION;

AMINES;

COMPLEMENT; DIAZEPAM; ISOFLURANE; KETAMINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 166 32; PADGEM PROTEIN; PANCURONIUM BROMIDE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; BABOON; BLOOD SAMPLING; BREATHING RATE; CARDIOPULMONARY BYPASS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMETRY; DRUG EFFECT; IMMUNOFLUORESCENCE; INDUCED HYPOTHERMIA; INSPIRATORY CAPACITY; INTRAVENOUS CATHETER; LEUKOCYTE ACTIVATION; MONOCYTE; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; TIDAL VOLUME;

EID: 15444373209     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2004.07377.x     Document Type: Conference Paper

References (11)

1. Ko W, Hawes AS, Lazenby WD. Myocardial reperfusion injury: platelet-activating factor stimulates polymorphonuclear leukocyte hydrogen peroxide production during myocardial perfusion. J Thorac Cardiovasc Surg 1991;102:297-308.
2. Kubes P, Ibbotson G, Russell J. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Am J Physiol 1990;259:G300-5.
3. Raschke P, Becker BF. Adenosine and PAF dependent mechanisms lead to myocardial reperfusion injury by neutrophils after brief ischemia. Cardiovasc Res 1995;29:569-76.
4. Faraday N. Platelets, perioperative hemostasis and anesthesia. Anesthesiology 2002;96:1042-3.
5. Rinder C, Fitch J. Amplication of the inflammatory response: adhesion molecules associated with platelet/white cell responses. J Cardiovasc Pharmacol 1996;27:S6-12.
6. Hsu LC. Biocompatibility in heparin-coated extracorporeal circuit. Perfusion 1996;11:256-63.
7. Malinauskas RA, Sade RM, Dearing JP. Blood damage in cardiotomy suction return. J Extracorpor Tech 1988;20:40-5.
8. Fung M, Loubser PG, Ündar A, et al, Inhibition of complement, neutrophil, and platelet activation by an anti-factor D monoclonal antibody in simulated cardiopulmonary bypass circuits. J Thorac Cardiovasc Surg 2001;122:113-22.
9. Ündar A, Eichstaedt HC, Clubb FJ Jr, et al. Novel anti-factor D monoclonal antibody inhibits complement and leukocyte activation in a baboon model of cardiopulmonary bypass. Ann Thorac Surg 2002;74:355-62.
10. Atkinson PM, Taylor DI, Chetty N. Inhibition of platelet aggregation by ketamine hydrochloride. Thromb Res 1985;40:227-34.
11. Nakagawa T, Hirataka H, Sato M, et al. Ketamine suppresses platelet aggregation possibly by suppressed inositol triphosphate formation and subsequent suppression of cytosolic calcium increase. Anesthesiology 2002;96:1147-52.